Comera rises on share sale agreement

Comera Life Sciences Holdings

01/09/2022 11:22

** Drug developer Comera Life Sciences Holdings' shares
 CMRA.O  rise 40% to $2.48 - among the highest pct. gainers
across U.S. exchanges premarket
    ** Co enters into an agreement with Arena Business Solutions
Global SPC II to sell shares worth up to $15 mln over a 36-month
period  urn:newsml:reuters.com:*:nGNXy3Xj9
    ** Agreement allows option to increase stock offering by an
additional $15 mln
    ** Line of credit provides opportunity to invest in co's
pipeline and proprietary formulation platform - Comera CEO
    ** Up to Wednesday's close, stock was down ~76% YTD 

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))